Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 5, 2025Food FrontiersOpen Access

Metabolite‐Guided Acetylation Therapy: Astragaloside IV Reverses Diabetic Nephropathy via Gna13‐Driven Purine Metabolic Reprogramming

View Full Paper
Ask AI
Bookmark
Share

Authors

SQShi QiuSGSifan GuoDXDandan Xie

Discussion

Loading...

Member takes

Overview

This study reveals how astragaloside IV impacts purine metabolites in diabetic nephropathy, indicating Gna13's role as a therapeutic target.

Key Points

  • Astragaloside IV reversed diabetic nephropathy by normalizing purine metabolites, suggesting a novel treatment pathway.
  • Key findings show significant restoration of Gna13 acetylation in diabetic models, linking it to improved renal function.
  • The approach utilized high-resolution mass spectrometry imaging and acetylproteomics for detailed analysis of purine metabolism.
  • The results support a shift towards targeted dietary interventions, emphasizing the role of bioactive compounds in metabolic diseases.

Cite This Study

Qiu et al. (2025) studied this question.

synapsesocial.com/papers/68c23922b210217d6477a143https://doi.org/10.1002/fft2.70107
View Full Paper
Ask AI
Bookmark
Share